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In 2008, the International Society for Vascular Health (ISVH) continued its 
international expansion with the establishment of regional operations in the USA, 
Japan, and Australasia. In addition the ISVH held its 3rd annual China Week.
In the USA, May 2008 saw the creation of an ongoing partnership between ISVH 
and the American Society of Hypertension (ASH). An ofﬁ  cial session was held by 
ISVH at the twenty-third annual ASH Congress, held in New Orleans on May 16th.  The 
session consisted of two lively debates. The ﬁ  rst discussed “Therapeutic modiﬁ  cation of 
arterial stiffness – dream or reality?” The moderator was Prof. Joseph Izzo (New York, 
USA). Arguing for the motion was Prof. James Cameron (Melbourne, Australia), and 
against was Prof. John Cockcroft (Cardiff, UK). An extremely active debate followed. 
The discussion is available on the ofﬁ  cial ASH Congress CDROM.
The second debate asked the topical question “Do novel biomarkers improve the 
diagnosis and management of cardiovascular disease?” The moderator was Prof. Jay 
Cohn (Minneapolis, USA).
Arguing that they do indeed improve management was Prof. Kennedy Cruickshank 
(Manchester, UK), and for the defense was Prof. Ernesto Schiffrin (Canada). Another 
challenging discussion followed.
Finally the debates were summarized by the Chairperson, Prof. Suzanne Oparil 
(Alabama, USA).  In the ofﬁ  cial response ratings issued by ASH, these debates were 
among the highest rated of all ASH sessions. The audience reactions were extremely 
positive.
The ISVH will continue this format with sessions at the next ASH Congress, the 
twenty-fourth ASH, to be held in San Francisco from May 5–8, 2009.
The third ISVH China Week was held on June 21–28, 2008. The Honorary 
Chairman was Prof. Lansheng Gong (Shanghai, China), and the President of ISVH 
China, Prof. Hongyu Wang (Beijing, China). The ﬁ  rst congress was held in Guangzhou, 
and chaired by Prof. Jianfang Luo (Guangdong Hospital, Guangzhou, China). The 
guest speaker was Prof. Kenji Takazawa (Tokyo, Japan) who delivered a well-received 
lecture “Don’t discuss systolic pressure without measuring AI”.
The second congress was held in Shanghai and was split between the two largest 
hospitals, Ruijin Hospital (Prof. Ruiyan Zhang) and Jiangsu Hospital (Prof. Changwu 
Ruan). The guest speaker was Prof. Kohji Shirai who lectured on “CAVI as a marker 
of arteriosclerosis in the metabolic syndrome”. The third congress, the ofﬁ  cial ISVH 
China Session, was held in Hohhot, Inner Mongolia from June 26–28, 2008 under 
the patronage of the Government of China and the Inner Mongolia Medical Society, 
chaired by Prof. Guohua Zhang. ISVH was proud to have the attendance of  Dr. Chen, 
the Chinese Minister of Health. Over 500 doctors attended this 2 day meeting, and a 
letter of thanks was received from the Dr. Chen, wishing ISVH every success in the 
prevention of vascular disease worldwide. The guest speakers were Prof. Suzanne 
Oparil and Prof. Yui-Fai Chen (USA). Prof. Oparil gave two lectures, “Estrogen and 1146
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female arteries; the secret to a long life” and ‘‘Recent 
advances in the treatment of Hypertension”.
The fourth ISVH China Week will be held from June 
16–25, 2009. Congresses will take place in Guangzhou, 
Guiyang, and Beijing. A full programme of meetings will 
be posted over the coming weeks on the ISVH Website 
(www.isvh.net), including guest speakers from USA, Europe, 
and Australasia.
The ofﬁ  cial opening of the Japanese branch of  ISVH was 
held in Tokyo on July 13, 2008. Over 400 doctors attended 
the opening ceremony, which was chaired by Prof. Kenji 
Takazawa (Tokyo, Japan). The guest lectures were given by 
Prof. John Cockcroft (Cardiff, UK) who discussed the impor-
tance of arterial markers in vascular health management.
The second ISVH Japan Congress will be held in summer 
2009. Full details will be posted shortly.
The ﬁ  rst Australasian regional meeting of  ISVH was held 
in Adelaide from August 6–7, 2008. The President of ISVH 
Australasia is Prof. James Cameron (Melbourne, Australia) 
and the Secretary is Bronwyn Kingwell (Melbourne, 
Australia). Among a variety of topics actively debated was 
“Is there a place for assessing arterial mechanics/function in 
clinical medicine?” delivered by Prof. Kennedy Cruickshank 
(Manchester, UK). A second ISVH Australasian Congress is 
being planned for 2009, as well as an International Congress 
in Europe.
ISVH would like to thank its founding sponsors for their 
continuing assistance. In particular:
•  Servier Australia, for support of ISVH Australasia,
•  Fukuda Denshi; for support of ISVH China,
•  Omron, for support of ISVH Japan,
•  MicroLife for support of ISVH in the USA.
ISVH welcomes new members. To join us, please 
contact us through the ISVH website (www.isvh.net). 
This website will shortly be updated and revised to accom-
modate the expanding role of ISVH in vascular health 
worldwide.
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